CVS Health (CVS) Tops Q2 EPS by 22c, Sales Beat; Raises Outlook
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $94.01 -3.24%
Financial Fact:
Dividends declared per common share (in dollars per share): 0.43
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Dividends declared per common share (in dollars per share): 0.43
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.40, $0.22 better than the analyst estimate of $2.18. Revenue for the quarter came in at $80.6 billion versus the consensus estimate of $76.4 billion.
GUIDANCE:
CVS Health sees FY2022 EPS of $8.40-$8.60, versus prior of $8.20-$8.40 and the consensus of $8.36.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- XP Inc. (XP) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
